Ahmet Özdemir

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Brain Metastases

Small Cell Lung Cancer

Nitric Oxide Synthase

Top Venues

International journal of molecular sciences

Archiv der Pharmazie

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Iman Baramaki, Mehlika Dilek Altintop, Rana Arslan, Feyza Alyu Altınok, Ahmet Özdemir, Ilhem Dallali, Ahmed Hasan, Nurcan Bektaş Türkmen
Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents. ACS omega 9 (10) (2024)
Iman Baramaki, Mehlika Dilek Altintop, Rana Arslan, Feyza Alyu Altınok, Ahmet Özdemir, Ilhem Dallali, Ahmed Hasan, Nurcan Bektaş Türkmen
Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents. ACS omega 9 (10) (2024)
Mehlika Dilek Altintop, Begüm Nurpelin Sağlık Özkan, Ahmet Özdemir
Design, Synthesis, and Evaluation of New Pyrazolines As Small Molecule Inhibitors of Acetylcholinesterase. ACS omega 9 (29) (2024)
Mehlika Dilek Altintop, Begüm Nurpelin Sağlık Özkan, Ahmet Özdemir
Design, Synthesis, and Evaluation of New Pyrazolines As Small Molecule Inhibitors of Acetylcholinesterase. ACS omega 9 (29) (2024)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Mehlika Dilek Altintop, Malihe Moradzadeh, Cüneyt Türkeş, Remzi B Öztürk, Zerrin Cantürk, Sukru Beydemir, Ahmet Özdemir
A new series of hydrazones as small-molecule aldose reductase inhibitors. Archiv der Pharmazie (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Mehlika Dilek Altintop, Zerrin Cantürk, Ahmet Özdemir
Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents. ACS omega 8 (45) (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Mehlika Dilek Altintop, Belgin Sever, Gülşen Akalın Çiftçi, İpek Ertorun, İbrahim Ozkan Alatas, Ahmet Özdemir
A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition. Archiv der Pharmazie 355 (9) (2022)
Ahmet Özdemir, Halilibrahim Çiftçi, Belgin Sever, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Mehlika Dilek Altintop
A New Series of Indeno[1,2- c ]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy. Molecules (Basel, Switzerland) 27 (2) (2022)
Turana Orujova, Abdulilah Ece, Gülşen Akalın Çiftçi, Ahmet Özdemir, Mehlika Dilek Altintop
A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer. Drug development research (2022)
Belgin Sever, Mehlika Dilek Altintop, Ahmet Özdemir, Gülşen Akalın Çiftçi, Doha E Ellakwa, Hiroshi Tateishi, Mohamed Osman Radwan, Mahmoud A A Ibrahim, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi, Taha Farouk Shehata Ali
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Molecules (Basel, Switzerland) 25 (21) (2020)
Halide Edip Temel, Mehlika Dilek Altintop, Ahmet Özdemir
Synthesis and Evaluation of a New Series of Thiazolyl-pyrazoline Derivatives as Cholinesterase Inhibitors. Turkish journal of pharmaceutical sciences 15 (3) (2018)
Ahmet Özdemir, Belgin Sever, Mehlika Dilek Altintop, Elif Kaya Tilki, Miriş Dikmen
Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress. Molecules (Basel, Switzerland) 23 (9) (2018)
Mehlika D Altintop, Belgin Sever, Derya Osmaniye, Begüm N Sağlık, Ahmet Özdemir
Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors. Archiv der Pharmazie 351 (7) (2018)